CCL7 and pancreatic ductal adenocarcinoma: Indeed, similar to our observations in the CCL7 3'UTR, a variant closely located to a miR-199a binding site at the 3'UTR of the HIF1A gene, is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes (58).